Table 3.

The association of CCND1 G870A polymorphism with glioma risk

	Patients	Controls	OR (95% CI)1	P value
General genotype
GG	61	82	1.00 (Reference)
AG	47	65	2.972 (0.782-3.874)	0.09
AA	59	33	3.661 (1.658-6.287)	0.01
Dominant genotype
GG	61	82	1.00 (Reference)
AG + AA	106	98	3.076 (0.899-5.919)	0.08
Recessive genotype
GG + AG	108	147	1.00 (Reference)
AA	59	33	2.168 (0.825-5.917)	0.11
Allele frequency
G	169	229	1.00 (Reference)
A	165	131	3.926 (2.172-7.889)	0.007

¹Adjusted for sex, age, smoking status, and drinking status.